|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | FUNDEMENTAL ANALYSIS OF PHARMA COMPANIES (A STUDY ON AUROBINDO,CADILA,CIPLA,DIVIS,DR REDDYS) |
| Authors Name: | N.sandhya rani , Dr.C.Mallesha |
| Unique Id: | IJSDR2103008 |
| Published In: | Volume 6 Issue 3, March-2021 |
| Abstract: | Fundamental analysis is a way to show up the ‘correct price’ of the security. Its goal is to recognize the under priced and overpriced securities in the market so that the investment decision-buying and selling of shares can be made. A share is said to be undervalued if its current market value is less than the ‘correct price’ known as ‘intrinsic value’ or ‘true value’. Conversely, it is said to be overvalued if the current market value is above its intrinsic value. Top down approach is used for carrying out Fundamental Analysis. The present study aims at carrying out the Fundamental analyses of five leading companies of Indian pharmaceutical industry and estimating their intrinsic value to make investment decisions. The pharmaceutical industry is one of the main industries in India. So, the investment in the shares and securities of pharmaceutical companies seems to be profitable. Five leading pharmaceutical companies Aurobindo, cadila, Cipla, divis, dr reddys listed in the National Stock Exchange are selected for this study. The study is done using secondary data collected from Reserve Bank of India website, BSE website and Company Annual Reports for the period of last nine years from year 2011 to 2020. Fundamental Analysis of the five companies is carried out and their intrinsic value ranges are obtained from the EIC Analysis of these companies to make investment decisions. |
| Keywords: | Fundamental analysis,stock price,intrinsic value |
| Cite Article: | "FUNDEMENTAL ANALYSIS OF PHARMA COMPANIES (A STUDY ON AUROBINDO,CADILA,CIPLA,DIVIS,DR REDDYS)", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.6, Issue 3, page no.61 - 72, March-2021, Available :http://www.ijsdr.org/papers/IJSDR2103008.pdf |
| Downloads: | 000337362 |
| Publication Details: | Published Paper ID: IJSDR2103008 Registration ID:192939 Published In: Volume 6 Issue 3, March-2021 DOI (Digital Object Identifier): Page No: 61 - 72 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn